Global Necrotizing Fasciitis Market Size & Outlook
Global necrotizing fasciitis market, 2021-2033 (US$M)
Global necrotizing fasciitis market highlights
- The global necrotizing fasciitis market generated a revenue of USD 1,027.2 million in 2024 and is expected to reach USD 2,097.8 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 8.3% by 2033.
- In terms of segment, type i (polymicrobial) accounted for a revenue of USD 1,111.5 million in 2024.
- Type I (Polymicrobial) is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
Global data book summary
| Market revenue in 2024 | USD 1,027.2 million |
| Market revenue in 2033 | USD 2,097.8 million |
| Growth rate | 8.3% (CAGR from 2025 to 2033) |
| Largest segment | Type i (polymicrobial) |
| Fastest growing segment | Type I (Polymicrobial) |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type I (Polymicrobial) |
Other key industry trends
- In terms of revenue, the North America accounted for 38.1% of the global necrotizing fasciitis market in 2024.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Necrotizing Fasciitis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| CSL Behring | View profile | 5001-10000 | King Of Prussia, Pennsylvania, United States, North America | http://www.cslbehring.com/ |
| Octapharma AG | View profile | 10001+ | Lachen, Schwyz, Switzerland, Europe | http://www.octapharma.com/en.html |
| Basilea Pharmaceutica Ltd | View profile | 147 | Hegenheimermattweg 167b, Allschwil, Switzerland, 4123 | https://www.basilea.com |
| Hikma Pharmaceuticals PLC | View profile | 2150 | 1 New Burlington Place, London, United Kingdom, W1S 2HR | https://www.hikma.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| Gilead Sciences Inc | View profile | 18000 | 333 Lakeside Drive, Foster, CA, United States, 94404 | https://www.gilead.com |
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Global necrotizing fasciitis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to necrotizing fasciitis market will help companies and investors design strategic landscapes.
Type i (polymicrobial) was the largest segment with a revenue share of 108.21% in 2024. Horizon Databook has segmented the Global necrotizing fasciitis market based on type i (polymicrobial) covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Necrotizing Fasciitis Type Outlook (Revenue, USD Million, 2021-2033)
- Type I (Polymicrobial)
- Type II (Monomicrobial)
- Type III (Gas gangrene / clostridial myonecrosis)
- Global Necrotizing Fasciitis Treatment Outlook (Revenue, USD Million, 2021-2033)
- Empiric broad-spectrum antibacterials
- MRSA-coverage add-ons
- Antitoxin adjunct for invasive GAS
- Pathogen-targeted antibacterial regimens
- Antifungals for necrotizing fungal infections
- Immunotherapies
- Global Necrotizing Fasciitis Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Other
Reasons to subscribe to Global necrotizing fasciitis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global necrotizing fasciitis market databook
-
Our clientele includes a mix of necrotizing fasciitis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global necrotizing fasciitis market , including forecasts for subscribers. This global databook contains high-level insights into Global necrotizing fasciitis market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global necrotizing fasciitis market size, by regions, 2021-2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
